Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. Immunicom's cancer therapy is expected to allow the body’s natural immune system to directly attack cancer while enhancing the effects of other cancer treatments.